MPR and NLR as Prognostic Markers in ICU-Admitted Patients with COVID-19 in Jazan, Saudi Arabia

References

• World Health Organization. Available from: https://covid19.who.int/. Accessed November 11, 2021.
   Google Scholar
• Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol. 2020;92(4):455–459. doi:10.1002/jmv.2568831994738
   PubMed Web of Science ®Google Scholar
• Lai C, Shih T, Ko W, Tang H, Hsueh P. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.10592432081636
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
   PubMed Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/nejmoa200203232109013
   PubMed Web of Science ®Google Scholar
• Wang T, Du Z, Zhu F, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395(10228):E52. doi:10.1016/S0140-6736(20)30558-432171074
   PubMed Web of Science ®Google Scholar
• Kerboua KE. NLR: a Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19. Immunol Invest. 2021;50(1):92–100. doi:10.1080/08820139.2020.177385032482134
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):1–12. doi:10.1186/s12967-020-02374-031900168
   PubMed Web of Science ®Google Scholar
• Zhong Q, Peng J. Mean platelet volume/platelet count ratio predicts severe pneumonia of COVID-19. J Clin Lab Anal. 2021;35(1):1–9. doi:10.1002/jcla.23607
   Web of Science ®Google Scholar
• Ozcelik N, Ozyurt S, Yilmaz Kara B, Gumus A, Sahin U. The value of the platelet count and platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol. 2021;93(4):2221–2226. doi:10.1002/jmv.2664533135801
   PubMed Web of Science ®Google Scholar
• Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–647. doi:10.1016/j.ajem.2019.10.02331785981
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Mcnamara MG, Šeruga B, et al. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: a Systematic Review and Meta-Analysis. JNCI: Journal of the National Cancer Institute. 2014;106(6). doi:10.1093/jnci/dju124
   Google Scholar
• Liu Z, Li X, Zhang M, et al. The role of Mean Platelet Volume/platelet count Ratio and Neutrophil to Lymphocyte Ratio on the risk of Febrile Seizure. Sci Rep. 2018;8(1). doi:10.1038/s41598-018-33373-3
   Web of Science ®Google Scholar
• Yang A-P, Liu J-P, Tao W-Q, Li H-M. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. doi:10.1016/j.intimp.2020.10650432304994
   PubMed Web of Science ®Google Scholar
• Gorelik O, Izhakian S, Barchel D, et al. Prognostic significance of platelet count changes during hospitalization for community-acquired pneumonia. Platelets. 2017;28(4):380–386. doi:10.1080/09537104.2016.121903227682027
   PubMed Web of Science ®Google Scholar
• Kim CH, Kim SJ, Lee MJ, et al. An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock. PLoS One. 2015;10(3):e0119437. doi:10.1371/journal.pone.011943725742300
   PubMed Web of Science ®Google Scholar
• Martin-Garcia AC, Arachchillage DRJ, Kempny A, et al. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome. Heart. 2018;104(1):45. doi:10.1136/heartjnl-2016-31114428663364
   PubMed Web of Science ®Google Scholar
• Sayed AA, Allam AA, Sayed AI, Alraey MA, Joseph MV. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia. Saudi Med J. 2021;42(4):370LP. doi:10.15537/smj.2021.42.4.2020081833795491
   PubMed Web of Science ®Google Scholar
• Health. M of. Weqaya Saudi Center for Disease Prevention and Control. Coronavirus Disease 19 (COVID-19) Guidelines; 2020. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Coronavirus-Disease-2019-Guidelines-v1.2.pdf. Accessed November 11, 2021.
   Google Scholar
• Albalawi O, Alharbi Y, Bakouri M, et al. Clinical characteristics and predictors of mortality among COVID-19 patients in Saudi Arabia. J Infect Public Health. 2021;14(8):994–1000. doi:10.1016/j.jiph.2021.06.00534153731
   PubMed Web of Science ®Google Scholar
• Alharthy A, Aletreby W, Faqihi F, et al. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: a Retrospective Study. J Epidemiol Glob Health. 2021;11(1):98–104. doi:10.2991/jegh.k.200928.00133095982
   PubMed Web of Science ®Google Scholar
• Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection. Am J Clin Pathol. 2021;155(3):364–375. doi:10.1093/ajcp/aqaa23133269374
   PubMed Web of Science ®Google Scholar
• Wu J, Wu X, Zeng W, et al. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features. Invest Radiol. 2020;55(5):257–261. doi:10.1097/RLI.000000000000067032091414
   PubMed Web of Science ®Google Scholar
• Güçlü E, Kocayiğit H, Okan H, et al. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras. 2929;66(8):1122–1127. doi:10.1590/1806-9282.66.8.1122
   Google Scholar
• Zampieri FG, Ranzani OT, Sabatoski V, et al. An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients. Ann Intensive Care. 2014;4(1):1–8. doi:10.1186/s13613-014-0020-124401163
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou X, Zhu C, et al. Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19. Front Mol Biosci. 2020;7(July):1–7. doi:10.3389/fmolb.2020.0015732039235
   PubMed Web of Science ®Google Scholar
• Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi:10.1016/j.ebiom.2020.10276332361250
   PubMed Web of Science ®Google Scholar
• Nurlu N, Ozturk OO, Cat A, Altounk E, Gumus A. Could Some Laboratory Parameters Predict Mortality in COVID-19? Clin Lab. 2021;67. doi:10.7754/Clin.Lab.2021.201231
   Web of Science ®Google Scholar
• Huang G, Kovalic AJ, Graber CJ. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. Emerg Infect Dis. 2020;26(8):1839–1841. doi:10.3201/eid2608.20116032384045
   PubMed Web of Science ®Google Scholar
• Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;16(24):647. doi:10.1186/s13054-020-03374-8
   Web of Science ®Google Scholar
• Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: what it shows and what can be learned. Immunol Lett. 2020;225:31–32. doi:10.1016/j.imlet.2020.06.01332569607
   PubMed Web of Science ®Google Scholar
• Ackermann M, Anders H-J, Bilyy R, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28:1–15. doi:10.1038/s41418-021-00805-z33318600
   PubMed Web of Science ®Google Scholar
• Zeng Z, Feng S, Chen G, Wu J. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study. BMC Infect Dis. 2021;21(1):80. doi:10.1186/s12879-021-05796-333461497
   PubMed Web of Science ®Google Scholar
• Tatum D, Taghavi S, Houghton A, Stover J, Toraih E, Duchesne J. Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana COVID-19 Patients. Shock. 2020;54(5):652–658. doi:10.1097/SHK.000000000000158532554992
   PubMed Web of Science ®Google Scholar
• Yufei Y, Mingli L, Xuejiao L, et al. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19). Scand J Clin Lab Invest. 2020;80(7):536–540. doi:10.1080/00365513.2020.180358732804580
   PubMed Web of Science ®Google Scholar
• Sy A, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to- Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12(7):448–453. doi:10.14740/jocmr424032655740
   PubMedGoogle Scholar
• Kong M, Zhang H, Cao X, Mao X, Lu Z. Higher level of Neutrophil-to-Lymphocyte is associated with severe COVID-19. Epidemiol Infect. 2020;5. doi:10.1017/S0950268820001557
   Web of Science ®Google Scholar
• Hamali HA. The Mighty Role Of Platelets In Immunity, Inflammation, Cancer And Angiogenesis. Majmaah J Heal Sci. 2020;8(1):65–81. doi:10.5455/mjhs.2020.01.008
   Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58. doi:10.2174/13816121179504980421247392
   PubMed Web of Science ®Google Scholar
• Polat E, Demir M. Platelet Indices’ Usefulness in Determining whether Patients with COVID-19 Should be Treated as an Outpatient or Inpatient: a Retrospective Study. Clin Lab. 2021;67(7). doi:10.7754/Clin.Lab.2020.201144
   Web of Science ®Google Scholar
• Sinha P, Matthay MA, Calfee CS. Is a “Cytokine Storm” Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152–1154. doi:10.1001/jamainternmed.2020.331332602883
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108(1):17–41. doi:10.1002/JLB.3COVR0520-272R32534467
   PubMed Web of Science ®Google Scholar
• Araya S, Mamo MA, Tsegay YG, et al. Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia. PLoS One. 2021;16(6):e0252939. doi:10.1371/journal.pone.025293934153056
   PubMed Web of Science ®Google Scholar
• Corrêa TD, Cordioli RL, Campos Guerra JC, et al. Coagulation profile of COVID-19 patients admitted to the ICU: an exploratory study. PLoS One. 2020;15(12):e0243604. doi:10.1371/journal.pone.024360433320874
   PubMed Web of Science ®Google Scholar
• Mehanna O, El Askary A, Ali E, El Esawy B, FathAlla T, Gharib AF. Impact of obesity and its associated comorbid conditions on COVID-19 presentation. Diabetes Metab Syndr Obes Targets Ther. 2021;14:409–415. doi:10.2147/DMSO.S287779
   Web of Science ®Google Scholar
• Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–1839. doi:10.1016/j.jiph.2020.07.01432788073
   PubMed Web of Science ®Google Scholar